Greenawalt, Danielle M.
Bristol-Myers Squibb (United States)
2 papers on CoChatORCID 0000-0002-6297-0753
Most cited papers
- Verified
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
Skoulidis, F., Goldberg, M. E., Greenawalt, D. M., Hellmann, M. D., Awad, M. M., Gainor, J. F., Schrock, A. B., Hartmaier, R. J., Trabucco, S. E., Gay, L., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,641
- Verified
Pretreatment Gene Expression Profiles Can Be Used to Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Duong, C., Greenawalt, D. M., Kowalczyk, A., Ciavarella, M. L., Raskutti, G., Murray, W. K., Phillips, W. A., & Thomas, R. J. S. (2007) · Annals of Surgical Oncology
Esophageal Cancer Research and TreatmentBreast Cancer Treatment Studies
Cited by 64
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free